In this Friday‑segment, a criminal defense attorney outlines the recent federal indictment of five individuals connected to actor Matthew Perry’s fatal ketamine overdose, describing the case as a “death‑results” prosecution. The speaker explains that defendants in such cases typically face minimum 20‑year sentences, with the government likely seeking life terms for the alleged ketamine supplier (“the ketamine queen”) and a physician who provided the drug. The indictment, a 34‑page document, includes extensive cooperation evidence such as encrypted text messages, clinic staff observations, and witness interviews. The attorney discusses key defense avenues, chiefly challenging whether ketamine was the direct cause of death given Perry’s history of polysubstance abuse, and the possibility of obtaining independent pathology. Even without a full acquittal defense, the speaker notes mitigation strategies: pleading guilty while arguing against a life sentence, leveraging cooperation to implicate higher‑level distributors, and highlighting other celebrity users to expand the investigation. The physician’s role is examined, suggesting potential broader misconduct that could be used in negotiations. The segment situates the case within a rising trend of aggressive federal prosecutions for fatal drug offenses, comparing it to prior fentanyl and heroin cases, and emphasizes the high stakes for defendants. The attorney invites listeners to contact the office for further discussion.
Chapters
Hey, so happy Friday everyone. What I'm going to start doing is kind of talking about some of the cases that are in the news on Fridays. And, you know, kind of a big one that we found out about yesterday was Matthew Perry's case and the fact that 5 people have been indicted, you know, in his ketamine death case. So I just want to kind of talk a little bit about what is going on here and what possible defenses may be here and what some of these defendants might be to do to reduce their sentences. Um, this is what's called a death results case. Um, we're seeing a lot of these lately, especially with like the rise of fentanyl. I've seen them kind of personally with fentanyl, with heroin, and now with ketamine. And so I've had an opportunity to look over the indictment against Jasvin Sangha and Salvador Plasencia. And, you know, I'll tell you, it's, it's a pretty damaging picture that has resulted from this. Typically in these cases, defendants are looking at a minimum of 20 years. I mean, even when plea agreements are reached with the government and they're allowed to plead to, you know, a non-death resulting case, they'll cross-reference that with a homicide statute. And they'll end up somewhere in like the 20-year range. Now, I think in this case, the feds are almost certainly looking for life sentences for both the ketamine queen, as they call her, and then also one of the physicians who was prescribed— or not prescribing, but who was providing the ketamine to Matthew Perry. And I say that because we can tell already that 3 of the other people who have been involved in this case have entered plea agreements and they're clearly cooperating. When you read this indictment, which is 34 pages long, I mean, it's very clear that the cooperation is extensive. Um, they have— the government, that is, the government has text messages from encrypted applications. Um, there's also in here, you can tell that there was somebody who was in a clinic who overheard somebody say something. So You know, it looks to me like they've been interviewing some of the doctor's staff or maybe patients. So there are a number of things that are, you know, factored into this investigation that's still ongoing. So the cooperation appears to be really very robust. Now, what could be some of the defenses here when you have a death results case? Kind of the big one that, as a criminal defense attorney, you're going to be looking at is whether or not the ketamine was the reason for the death. We know in this situation, for example, you know, Mr. Perry had a long history of, you know, addictions with other drugs as well. So, if you're the defendant, you're probably thinking, "Well, I mean, how do I know it was my ketamine? I mean, maybe he was also doing some other stuff." Now we know from the, from the government's position, I mean, they're saying right now, and it's important to keep in mind that right now it's the government that's completely driving the narrative here. Nobody has heard anything from the defense. But from the government's position, you know, they're saying that this ketamine was the direct cause of death. I imagine that the defense counsel is really going to be looking into this. They may seek to get like their own pathologist to, um, to you know, do whatever kind of scientific testing that they need to. But short of, you know, an actual defense, um, you know, to the crime itself— so let's just say, you know, that's the kind of defense you go to trial and you're trying to get an acquittal with that defense— even if you don't have that kind of defense, there are still things that the people here may be able to do to reduce their sentence. So maybe they say, you know, yes, I did this, I'm guilty, but I shouldn't have a life sentence, and here's why. And it's clear from the indictment again, I mean, you can always tell a lot from an indictment, especially when they're this, you know, meaty, that Sangha was getting this ketamine from somebody who she called the scientist. So it looks like there is somebody who is actually creating this ketamine, and likely Sangha is not the only distributor of it. So you know that the government also wants to get the person above her. So she may be able to use that for purposes of negotiating a lower sentence. There's also information in here suggesting that there are other celebrities, other people who are receiving this ketamine. And so again, I mean, if the government wants to more fully expand an investigation here, they may try to negotiate something with her in order to get, you know, other people implicated so that they can prosecute those other people. As for Dr. Placencia, it's not so clear what he has that, you know, that the government may be interested in. And it may be that it's just not in here, um, but, you know, maybe he— it's hard to believe that this is the first time that he's engaged in this kind of conduct, you know, just sort of providing ketamine to other people off script. I mean, it's extraordinary breach of his ethical duties as a doctor. It's hard to believe this was the first time. So, there may be some other people who might be implicated in other criminal acts that the government may be interested in. And again, that's the sort of thing that they may be able to leverage in order to get a lesser sentence at some point. But I expect this to be a very high-profile case and one that's going to continue. Right now, there are no incentives for Ms. Tseng Ha or Mr. Plasencia to plead guilty. So, if you're a criminal defense attorney, you're like, "Well, I'm just going to trial, you know, because the government's not giving me anything." And so, this could be really very interesting. I know the government wants to bring more of these cases. You know, as I mentioned sort of earlier, you know, we have a lot more dangerous drugs on the streets these days. And so the government is going to want to send a message that if, you know, you're involved in the trafficking of these sorts of drugs, I mean, there's going to be a very heavy price to pay. And I will tell you, just sort of in my practice, I usually handle clients, you know, once they've been convicted. But I've seen a number of people who have gotten these 20-year sentences and they weren't nearly as egregious as what's happened here. In fact, one client, for example, he and his girlfriend were both drug addicts, and they got the drugs, or he got the drugs for them to use together. She died, he didn't. He got 20 years. So that's what you're looking at with these sorts of prosecutions. So keep your eyes on it. It's going to be very interesting. If anyone has any questions about this case, case, I mean, please just feel free to reach out to our office, and, you know, we'd love to just kind of, you know, chat about it. It's sort of, it's interesting, interesting stuff. And so anyway, it's a Friday. Happy Friday, and hope you have a great weekend. Bye.
